Carregando...
Efficacy of Targeting SARS-CoV-2 by CAR-NK Cells
SARS-CoV-2, which causes COVID-19 disease, is one of greatest global pandemics in history. No effective treatment is currently available for severe COVID-19 disease. One strategy for implementing cell-based immunity involves the use of chimeric antigen receptor (CAR) technology. Unlike CAR T cells,...
Na minha lista:
| Publicado no: | bioRxiv |
|---|---|
| Principais autores: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Cold Spring Harbor Laboratory
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7430572/ https://ncbi.nlm.nih.gov/pubmed/32817942 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.08.11.247320 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|